Browse by Hotbed/Location
Filter News
Found 492,656 articles
-
Researchers at UCSF recently published research in the journal Science describing their use of a modified version of CRISPR gene editing to stimulate the activity of certain genes, resulting in the prevention of severe obesity in mice who had a genetic predisposition to extreme weight gain.
-
Shares of New Jersey-based Advaxis have plunged more than 28 percent in premarket trading after the company quietly disclosed that Amgen terminated its collaboration on an immuno-oncology program. The deal between the two companies was first inked in 2016 and had a value of up to $540 million.
-
Days after Axovant announced an end to focusing on its legacy small molecule portfolio in favor of gene therapies, the company announced it has licensed worldwide rights to two gene therapy programs from the University of Massachusetts School of Medicine.
-
Because many types of prostate cancer are very slow growing and generally diagnosed in older men, so-called “watchful waiting” is often the prescribed treatment plan. Now researchers are saying this may not be the best way.
-
December 14 Research Roundup: Lonesome George’s Genome, Alzheimer’s and Prostate Cancer Tests and...
12/14/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Earlier this week, the U.S. Food and Drug Administration cleared the company’s Investigational New Drug Application to allow the company to initiate clinical studies with Xeno-Skin, a product designed to provide help for patients who have suffered from significant burns.
-
U.S.-based Merck and Co. has made a deal to acquire French company Antelliq Group for about $2.4 billion. Antelliq is a digital technology company focused on services for veterinarians, farmers and pet owners.
-
FDA Scraps 2013 Generic Drug Label Proposal That Could Have Exposed Manufacturers to Lawsuits
12/14/2018
The rule could have allowed generic manufacturers to independently update safety data on drugs, which could have opened the companies to potential lawsuits over side effects. -
Study: The More Popular the Health-Related YouTube Video, the More Likely It Is to Be Inaccurate
12/14/2018
It should come as no surprise that not all information on the internet is reliable. It’s a largely unregulated wild, wild west that allows for anyone to put up any content they wish to. Which can be a particular problem when it comes to health-related content. -
The Medicines Company Prices $150 Million of Convertible Notes
12/14/2018
The Medicines Company today announced that it has priced its private offering of $150 million in aggregate principal amount of its convertible senior notes due 2024.
-
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
12/14/2018
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS
-
Emerald Textiles Continues Expansion in California Through the Acquisition of the Assets of MediClean Linen and Laundry in Los Angeles and Launch of a New Facility Build out in Northern California to Serve Expanding California Customer Base
12/14/2018
Emerald Textiles today announces the acquisition of the assets of MediClean Linen and Laundry, a Los Angeles-based healthcare linen service provider.
-
Lupus Research Alliance Applauds FDA's Fast Track Designation to Develop Baricitinib for Lupus
12/14/2018
The Lupus Research Alliance is pleased to share good news about a potential new treatment for systemic lupus erythematosus (SLE).
-
Women's Care Florida Announces New CMO; Dr. Donald Wilson Retires
12/14/2018
Women's Care Florida is pleased to announce that Helen M. Kuroki, MD, has been named as the company's chief medical officer. She succeeds Donald Wilson, MD, who is retiring on January 4, 2019.
-
Statement on Reuters Talc Article
12/14/2018
Johnson & Johnson (NYSE: JNJ) today issued the following statement regarding speculation about the safety of our products.
-
Pulse Biosciences, Inc. Announces Closing of Its $45 Million Rights Offering
12/14/2018
Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform, announced today that its rights offering has closed.
-
So Yummy And Good Morning America Break GUINNESS WORLD RECORDS™ Record For Most Cookies Iced In 1 Hour
12/14/2018
First Media's So Yummy, the number one food brand on social media, joined forces with Good Morning America on Thursday, December 13 to break a GUINNESS WORLD RECORDS™ record for the Most cookies iced in 1 hour.
-
TELADOC INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Teladoc Health, Inc. To Contact The Firm
12/14/2018
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Teladoc Health, Inc.
-
Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar
12/14/2018
Prestige BioPharma (“Prestige”) announced today that it has reached a licensing agreement with Cipla Limited (“Cipla”) for its trastuzumab biosimilar (HD201) under which Cipla will have exclusive rights to distribute and market the drug in selected emerging markets.
-
NRMP Pediatric Specialties Fall Match (PSFM) for Appointment Year 2019 is Largest in History
12/14/2018
The National Resident Matching Program® (NRMP®) has released the results of the 2018 Pediatric Specialties Fall Match (PSFM) for appointment year 2019.